Trial intelligence / Profile preview

Bupropion and amantadine for sexual dysfunction in methadone-treated patients

IRCT20170606034348N5Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of bupropion and amantadine in sexual dysfunction, sponsored by Babol University of Medical Sciences. Started May 2018; status: completed.

02

Drugs

bupropionamantadine
03

Conditions

sexual dysfunction

Beyond the preview

Go deeper on IRCT20170606034348N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170606034348N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call